Balzarini & Watson
Local: 412-471-1200
Toll Free: 866-316-2111
Home and Hospital Visits / Contingency Fee BasisFreeConsultation

Over 135 Years of Combined Experience In Personal Injury and Wrongful Death

Diabetes drug may cause rare side effect

People in Pennsylvania who take a kind of drug known as an SGLT2 inhibitor for type 2 diabetes may have twice as much likelihood of developing a condition called diabetic ketoacidosis than people who take a different class of inhibitors. However, researchers say that the condition is still very rare and that the possibility of this side effect is low enough that it should not stop people from taking SGLT2 inhibitors. Around 1 in 1,000 people who take the inhibitors will suffer from the condition.

Ketoacidosis is more common in people with type 1 diabetes, and therefore, researchers caution that it is important for physicians to be aware of the possibility that people with type 2 diabetes might develop the condition as well. Abdominal pain, vomiting, swelling in the brain and shortness of breath may all indicate ketoacidosis, and it can be deadly if it is not treated.

The study appeared in the "New England Journal of Medicine," and it was conducted by researchers in Boston at Brigham and Women's Hospital. It examined data on 40,000 people who all had type 2 diabetes.

A failure to diagnose may happen for a number of reasons. Following such a failure, a patient might wish to file a lawsuit that alleges medical malpractice. A successful lawsuit will first show that the person was harmed in some way by the lack of diagnosis. This harm could be a delay in treatment that could result in a significant medical setback. The lawsuit should also show that the medical professional was negligent in some way or that the patient received an inferior standard of care. For example, a doctor might not adequately explore a patient's family history or symptoms.

No Comments

Leave a comment
Comment Information